CRS Mitigation Strategies clinical trials

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

This study is testing a new medicine called tarlatamab for adults with small cell lung cancer. It aims to see how safe it is, how well people tolerate it, and how it moves through the body.